≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Juvenile Open Angle Glaucoma

EFO Endpoint Browser PheWeb

H7_GLAUCOMA_JOAG

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Pre-conditions: 4<=EVENT_AGE<=40

Registry filters:

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

214

6. Filter based on genotype QC (FinnGen only)

214

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF6

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1785 745 1023
Only index persons 1675 714 961
Unadjusted period prevalence (%)
Whole population 0.03 0.02 0.03
Only index persons 0.03 0.03 0.04
Median age at first event (years)
Whole population 34.05 34.02 34.02
Only index persons 33.98 34.03 33.95

-FinnGen-

Key figures

All Female Male
Number of individuals 214 112 102
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 34.90 34.46 35.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
197
Matched controls
1969
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
114
Kela drug reimbursment
Glaucoma
372.8
186.1
169
31
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
298.0
162.4
149
20
S01ED51
ATC
timolol, combinations; ophthalmic
95.7
115.6
124
34
S01EE01
ATC
latanoprost; ophthalmic
133.8
110.6
112
19
S01ED01
ATC
timolol; ophthalmic
145.7
88.3
89
11
XCK00
NOMESCO Finland
Perimetry
38.3
70.4
91
43
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
163.7
65.6
66
6
S01EX03
ATC
NA
271.7
59.6
58
*
H40.0
ICD-10 Finland
Glaucoma suspect
24.6
53.8
79
52
S01EC03
ATC
dorzolamide; ophthalmic
607.1
49.7
47
*
S01EC04
ATC
brinzolamide; ophthalmic
50.7
48.8
58
16
S01EC01
ATC
acetazolamide; systemic
65.3
46.7
53
11
XCW99
NOMESCO Finland
Other investigative procedure of eye
14.4
43.5
80
89
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
43.3
40
*
S01EE03
ATC
bimatoprost; ophthalmic
90.9
39.8
43
6
S01EE05
ATC
tafluprost; ophthalmic
44.8
39.4
48
14
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
241.4
39.4
39
*
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
34.4
32
*
XCK10
NOMESCO Finland
Photography of fundus of eye
11.1
33.9
70
93
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
45.1
33.0
40
11
Z01.0
ICD-10 Finland
Examination of eyes and vision
7.7
30.0
81
164
H40.9
ICD-10 Finland
Glaucoma, unspecified
87.6
27.6
30
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
10.1
26.5
56
74
Z96.1
ICD-10 Finland
Presence of intraocular lens
11.7
25.5
49
54
H40.11
ICD-10 Finland
Low pressure glaucoma
50.2
25.4
30
7
S01EE04
ATC
travoprost; ophthalmic
54.0
24.0
28
6
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
18.7
24.0
37
24
XCH00
NOMESCO Finland
Eye pressure measurement
14.9
22.0
37
30
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
21.2
20
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
16.4
19.9
32
23
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
4.3
19.1
92
330
CHD99
NOMESCO Finland
Other filtering operation
+∞
19.1
18
*
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
+∞
19.1
18
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.8
19.0
60
138
CHD00
NOMESCO Finland
Laser trabeculoplasty
110.7
18.9
20
*
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
209.0
18.9
19
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.0
18.7
105
434
H26.4
ICD-10 Finland
After-cataract
13.0
18.6
33
30
S01ED02
ATC
betaxolol; ophthalmic
58.4
18.3
21
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
73.7
18.1
20
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
9.4
17.6
37
47
S01EA03
ATC
apraclonidine; ophthalmic
+∞
16.9
16
*
S01EA02
ATC
dipivefrine; ophthalmic
+∞
16.9
16
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
+∞
16.9
16
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
10.4
16.2
32
36
WX140
NOMESCO Finland
Parabulbar anesthesy
16.6
15.8
25
17
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
29.8
14.6
19
7
3708
FHL
Trabeculectomy or equivalent
+∞
13.7
13
*
S01EB01
ATC
pilocarpine; ophthalmic
149.8
13.6
14
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
53.7
13.0
15
*
CS494
NOMESCO Finland
Other visual field testing
18.9
12.8
19
11
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
26.4
12.7
17
7
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
12.6
12
*
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
23.1
12.2
17
8
H40.12
ICD-10 Finland
Pigmentary glaucoma
69.2
11.7
13
*
S01BC03
ATC
diclofenac; ophthalmic
14.9
11.7
19
14
Z3229
NOMESCO Finland
Other healthcare associate professional
5.5
11.6
35
74
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
11.6
11
*
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
16.3
11.6
18
12
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
37.4
11.4
14
*
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
18.4
11.4
17
10
H3603, E103
ICD-10 Finland
NA
13.9
11.4
19
15
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
5.7
11.3
33
67
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
19.2
10.9
16
9
XCH05
NOMESCO Finland
Eye pressure longterm registration
29.9
10.9
14
5
3651E
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA INFANTILE SEU JUVENILE]
+∞
10.5
10
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.8
10.4
35
84
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
9.3
10.3
21
25
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
15.7
10.2
16
11
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.7
10.1
35
86
CKC15
NOMESCO Finland
Panretinal photocoagulation
42.4
10.1
12
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
21.4
9.9
14
7
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
6.0
9.8
27
51
A10AA02
ATC
NA
6.5
9.7
25
43
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
6.1
9.6
26
48
ZXA10
NOMESCO Finland
Bilateral
3.4
9.5
51
184
S01EC54
ATC
brinzolamide, combinations; ophthalmic
23.0
9.5
13
6
Q15.0
ICD-10 Finland
Congenital glaucoma
+∞
9.4
9
*
A10AA01
ATC
NA
6.2
9.1
24
43
H04AA01
ATC
glucagon; nasal, parenteral
6.4
8.9
23
40
WX100
NOMESCO Finland
Conjunctival surface anesthesia
5.5
8.9
26
53
A10AE04
ATC
insulin glargine; parenteral
4.5
8.9
32
82
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
9.2
8.5
17
20
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.1
8.4
20
31
37597
ICD-8 Finland
Glaucoma, Suspicio glaucomatis
+∞
8.4
8
*
H26.2
ICD-10 Finland
Complicated cataract
15.3
8.3
13
9
CKD40
NOMESCO Finland
Endophotocoagulation of retina
23.1
8.1
11
5
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
6.2
8.1
21
37
103
Kela drug reimbursment
Diabetes, insulin-treated
2.8
8.0
57
248
H16.0
ICD-10 Finland
Corneal ulcer
5.8
8.0
22
42
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
8.0
56
239
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
46.8
7.8
9
*
ZXC20
NOMESCO Finland
Use of chemical agents
46.8
7.8
9
*
H40
ICD-10 Finland
Glaucoma
46.8
7.8
9
*
H40.8
ICD-10 Finland
Other glaucoma
46.8
7.8
9
*
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
19.3
7.7
11
6
A10AE05
ATC
insulin detemir; parenteral
4.7
7.6
25
59
ZXA05
NOMESCO Finland
Left side
2.8
7.5
54
236
H27.0
ICD-10 Finland
Aphakia
+∞
7.3
7
*
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
+∞
7.3
7
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
12.7
7.2
12
10
H25.1
ICD-10 Finland
Senile nuclear cataract
3.4
7.1
35
118
H04.10
ICD-10 Finland
Dry eye syndrome
3.7
7.0
30
91
CKC10
NOMESCO Finland
Local photocoagulation of retina
11.5
6.9
12
11
T89
ICPC
Diabetes insulin dependent
5.0
6.8
21
46
Z94.7
ICD-10 Finland
Corneal transplant status
41.5
6.8
8
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
10.6
6.6
12
12
ZXA00
NOMESCO Finland
Right side
2.5
6.5
54
254
S01FA04
ATC
cyclopentolate; ophthalmic
14.9
6.5
10
7
CKD15
NOMESCO Finland
Injection of vitreous substitute
72.1
6.5
7
*
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
72.1
6.5
7
*
CHD35
NOMESCO Finland
Laser goniopuncture
72.1
6.5
7
*
H40.1
ICD-10 Finland
Primary open-angle glaucoma
72.1
6.5
7
*
S01FA01
ATC
atropine; ophthalmic
27.6
6.3
8
*
H3603, E113
ICD-10 Finland
NA
27.6
6.3
8
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.6
6.1
20
47
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.4
6.1
15
25
CHC05
NOMESCO Finland
Iridotomy
10.5
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012516) Albumin [Mass/volume] in Urine
77
408
2.39
8.04
5.8
3.4
mg/l
932.6
231.0
0.39
51
271
(3020682) Albumin/Creatinine [Ratio] in Urine
78
431
2.27
7.27
7.0
4.0
mg/mmol
18.9
10.6
0.43
53
284
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
28
103
2.98
5.97
7.4
3.4
ng/l
147.0
79.1
0.92
28
95
(3009508) Creatinine [Moles/volume] in Urine
79
470
2.08
5.90
5.6
3.2
mmol/l
6.9
8.4
2.36
72
408
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
21
5.47
5.58
1.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
40
188
2.39
5.27
2.6
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
72
3.13
5.03
4.7
7.0
mmol/l
23.0
24.8
1.15
21
72
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
25
4.58
4.62
2.4
2.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
94
643
1.82
4.38
9.9
6.6
mmol/l
1.2
1.2
0.74
89
594
(3020630) Protein [Mass/volume] in Serum or Plasma
24
97
2.66
4.31
3.0
2.8
g/l
67.7
68.1
0.08
24
89
(3026250) Tacrolimus [Mass/volume] in Blood
7
6
12.00
4.30
57.0
30.8
ug/l
8.9
6.4
—
7
6
(40768446) Kidney Pathology biopsy report
7
6
12.00
4.30
2.6
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
39
200
2.16
4.16
5.2
2.0
%
23.3
24.0
0.13
34
168
(3023368) Bacteria identified in Blood by Culture
63
385
1.90
4.16
5.8
4.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
68
429
1.86
4.05
7.8
3.8
ph
7.4
7.4
0.03
17
81
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
101
718
1.77
4.05
14.8
7.5
mmol/l
1.2
1.2
0.13
88
613
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
11
7.50
3.89
2.1
4.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
37
191
2.13
3.88
16.5
6.2
mmol/l
1.1
1.0
0.82
37
179
(3000494) Fungus identified in Specimen by Culture
35
181
2.12
3.65
1.7
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
242
1.97
3.58
3.3
2.3
e6/l
0.6
0.9
0.47
28
136
(3019550) Sodium [Moles/volume] in Serum or Plasma
197
1757
2.53
3.50
20.5
12.6
mmol/l
139.3
139.6
1.64
192
1715
(40761536) Microorganisms panel - Urine sediment
30
149
2.18
3.46
7.1
3.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
27
3.84
3.39
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
70
468
1.74
3.36
6.1
2.8
e6/l
125.4
165.9
0.09
57
355
(3023103) Potassium [Moles/volume] in Serum or Plasma
197
1765
2.46
3.32
21.3
12.6
mmol/l
4.0
4.0
0.47
192
1716
(3030467) Casts [#/volume] in Urine by Automated count
64
419
1.75
3.30
5.6
2.6
e6/l
0.2
0.3
1.36
51
312
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
7
8.77
3.28
1.0
1.0
miu/ml
1025.8
1190.1
—
6
7
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
146
2.14
3.24
3.7
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
15
5.49
3.22
1.5
1.3
pg
31.3
33.5
—
8
15
(3002032) Base excess in Venous blood by calculation
24
112
2.29
3.21
11.1
3.3
mmol/l
1.5
2.2
0.37
19
83
(3018095) Leukocytes [#/volume] in Urine
79
552
1.68
3.21
6.3
3.2
e6/l
25.2
135.5
1.08
59
380
(3004588) Protein electrophoresis panel - Serum or Plasma
19
80
2.51
3.16
2.0
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
66
441
1.72
3.15
5.9
3.6
estimate
0.0
0.0
0.50
30
169
(36304419) Bacteria [Presence] in Urine
64
424
1.73
3.15
4.9
2.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
68
459
1.71
3.12
1.9
2.1
u/l
194.9
197.9
0.01
63
437
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
223
1.92
3.09
3.6
2.4
e6/l
3.4
2.7
0.12
24
117
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
29
3.57
3.08
1.0
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
80
567
1.66
3.05
9.8
5.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
165
2.03
3.00
1.5
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
109
839
1.61
2.96
5.4
3.2
estimate
0.0
0.0
0.00
32
176
(3009261) Glucose [Presence] in Urine by Test strip
110
856
1.59
2.80
5.5
3.2
estimate
0.0
0.0
0.00
30
170
(3032080) INR in Blood by Coagulation assay
79
570
1.61
2.76
5.9
6.5
inr
1.1
1.1
0.31
36
183
(3037467) Urinalysis macro (dipstick) panel - Urine
141
1168
1.61
2.72
6.3
4.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
121
968
1.58
2.70
7.8
4.8
mmol/l
6.9
6.6
0.89
116
887
(3044889) 12 lead EKG panel
138
1141
1.59
2.65
3.6
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
557
1.60
2.64
5.3
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
28
151
1.98
2.62
3.2
2.7
%
1.8
1.7
0.20
28
137
(3015377) Calcium [Moles/volume] in Serum or Plasma
68
479
1.62
2.59
3.9
3.3
mmol/l
2.3
2.3
0.34
62
418
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
44
2.83
2.59
1.1
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
167
1.93
2.57
1.5
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
50
327
1.69
2.54
5.9
2.4
e6/l
5.2
4.9
0.09
45
285
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
238
1.78
2.52
4.2
3.0
ng/l
38.7
200.1
1.27
31
156
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
39
2.92
2.51
2.6
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
39
2.92
2.51
1.4
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
107
843
1.54
2.49
7.1
4.4
estimate
0.0
0.0
0.00
33
174
(1616796) Gas panel - Central venous blood
9
27
3.43
2.42
4.9
2.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
110
876
1.53
2.41
9.5
5.9
e9/l
0.6
0.5
1.19
98
785
(3021589) Normoblasts [#/volume] in Blood
98
764
1.52
2.36
14.8
8.7
e9/l
0.0
0.0
0.65
81
627
(3014051) Protein [Presence] in Urine by Test strip
9
28
3.31
2.33
2.9
1.5
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
28
3.31
2.33
4.1
2.2
kpa
4.9
5.1
—
9
28
(3027315) Oxygen [Partial pressure] in Blood
9
28
3.31
2.33
4.1
2.2
kpa
9.1
9.3
—
9
28
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
360
1.63
2.32
4.0
3.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
110
881
1.51
2.32
9.5
5.9
e9/l
0.0
0.0
0.54
98
790
(3013115) Eosinophils [#/volume] in Blood
113
914
1.50
2.25
9.7
6.2
e9/l
0.2
0.2
0.41
101
828
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
75
2.22
2.14
2.6
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
38
243
1.69
2.09
1.7
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
104
2.02
2.08
14.4
8.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
108
877
1.47
2.04
5.1
5.7
umol/l
9.4
10.5
1.01
99
834
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
183
1661
1.70
2.01
17.7
10.3
ml/min/173m2
89.8
89.7
0.01
148
1370
(3019198) Lymphocytes [#/volume] in Blood
111
909
1.46
1.99
9.5
6.0
e9/l
1.7
1.9
0.83
101
825
(3024928) Oxygen saturation in Venous blood
7
21
3.41
1.98
7.6
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
21
3.41
1.98
5.4
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
11
4.63
1.95
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
11
4.63
1.95
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
11
4.63
1.95
1.0
1.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
16
3.83
1.95
7.7
2.2
%
61.7
64.9
—
6
16
(3022096) Basophils/100 leukocytes in Blood
99
797
1.45
1.93
10.2
5.9
%
0.7
0.7
0.15
92
750
(4062490)
7
22
3.25
1.89
1.4
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
102
828
1.44
1.89
10.2
6.1
%
8.5
8.3
0.28
96
791
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
54
386
1.53
1.88
1.9
1.7
mg/l
0.8
1.0
0.38
44
295
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
13
59
2.28
1.88
2.2
1.9
g/l
1.2
1.4
0.36
13
52
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
12
4.24
1.83
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
12
4.24
1.83
1.0
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
56
406
1.51
1.83
3.4
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
82
642
1.45
1.83
8.2
4.6
g/l
35.7
36.4
0.51
76
607
(3006504) Eosinophils/100 leukocytes in Blood
101
825
1.42
1.78
10.1
5.8
%
2.7
2.8
0.10
95
780
(3013650) Neutrophils [#/volume] in Blood by Automated count
121
1022
1.42
1.76
12.3
9.5
e9/l
4.3
4.0
0.71
103
903
(3018010) Neutrophils/100 leukocytes in Blood
103
846
1.42
1.75
9.7
5.7
%
59.4
57.0
1.17
97
809
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
8
30
2.73
1.74
1.1
2.0
g/l
0.0
0.0
—
8
30
(3002030) Lymphocytes/100 leukocytes in Blood
103
852
1.40
1.66
10.0
5.9
%
26.9
28.8
0.87
97
812
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
59
443
1.46
1.61
1.8
1.7
mmol/l
1.4
1.4
0.02
51
383
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
48
346
1.50
1.60
2.6
2.9
ng/l
672.8
816.2
0.26
40
284
(3002179) Metamyelocytes/100 leukocytes in Blood
22
130
1.77
1.60
5.0
4.8
%
0.1
0.5
—
7
30
(3000330) Specific gravity of Urine by Test strip
13
64
2.10
1.57
3.9
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
44
2.34
1.55
1.8
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
84
677
1.40
1.55
3.7
2.3
nmol/l
76.7
73.8
0.38
79
623
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
84
679
1.39
1.52
5.6
3.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
21
2.91
1.51
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
17
286
0.56
1.50
1.5
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
42
299
1.50
1.49
5.9
2.4
mosm/kgh2o
501.6
555.3
0.76
37
252
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
57
432
1.44
1.48
1.3
1.3
u/ml
2.1
1.3
0.23
19
130
(3041096) Erythrocytes [Presence] in Urine by Automated
66
514
1.41
1.47
5.2
2.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
38
2.43
1.47
3.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
66
2.03
1.47
4.2
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
16
3.17
1.44
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
174
1596
1.48
1.44
5.0
4.5
mu/l
1.8
1.8
0.23
162
1479
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
146
1299
1.39
1.43
10.1
7.1
u/l
78.8
75.8
0.40
139
1224
(3004119) Hemoglobin [Mass/volume] in Venous blood
14
75
1.93
1.38
7.2
3.6
g/l
122.7
133.9
0.90
14
75
(3023420) DNA double strand Ab [Units/volume] in Serum
6
23
2.65
1.37
1.2
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
23
145
1.66
1.36
7.8
11.8
kpa
13.6
12.4
0.33
23
140
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
23
145
1.66
1.36
7.8
11.8
kpa
4.9
5.1
0.47
23
138
(3002256) Pathology report gross observation
28
186
1.58
1.35
1.4
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
12
62
1.99
1.30
7.4
2.6
%
1.3
1.6
0.33
12
62
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
18
2.82
1.29
1.6
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
32
225
1.50
1.21
3.9
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
110
1.69
1.20
6.2
2.5
ml/min/173m2
69.8
69.9
—
5
48
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
26
2.34
1.19
9.0
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
448
1.37
1.19
6.3
4.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
54
422
1.37
1.17
1.6
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
135
1.62
1.16
5.6
4.9
%
0.0
0.2
—
9
41
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
181
0.53
1.15
1.4
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
144
1.59
1.14
5.6
4.7
%
0.7
0.8
—
9
45
(3047181) Lactate [Moles/volume] in Blood
8
40
2.04
1.13
3.5
16.8
mmol/l
1.1
1.1
—
8
35
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
31
2.30
1.11
7.9
3.4
%
61.6
56.8
—
7
31
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
31
2.30
1.11
6.4
3.2
e9/l
4.5
4.7
—
7
31
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
567
1.32
1.07
1.8
1.8
pmol/l
94.6
94.7
0.00
39
294
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
60
1.88
1.05
1.5
1.6
g/l
0.2
0.2
0.35
11
60
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
34
2.09
1.04
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
76
1.76
1.01
1.8
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
171
1595
1.36
1.00
8.8
4.9
mmol/mol
44.3
38.9
5.12
160
1508
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
144
1313
1.30
0.99
4.1
3.9
pmol/l
14.5
14.6
0.02
131
1207
(40760888) Immunoglobulin light chains.free panel - Serum
5
23
2.20
0.98
3.8
3.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
36
1.98
0.98
1.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
55
1.86
0.93
2.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
22
153
1.49
0.90
12.2
19.7
inr
1.0
1.3
—
7
24
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
42
1.94
0.89
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
43
1.89
0.88
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
64
1.76
0.88
1.5
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
28
206
1.41
0.87
1.7
2.3
umol/l
4.4
5.9
0.98
21
176
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
96
1.60
0.87
1.2
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
129
1.52
0.87
5.7
4.9
%
0.0
0.0
—
7
34
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
113
0.52
0.86
1.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
359
0.72
0.85
2.5
2.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
65
1.73
0.84
10.9
17.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
106
1.55
0.81
2.2
2.7
u/l
160.9
3249.5
—
9
48
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
106
1.55
0.81
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
598
1.25
0.79
3.3
3.1
ng/l
43.1
30.3
0.30
43
346
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
27
0.00
0.78
0.0
1.3
—
11.9
—
0
22
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
108
0.54
0.74
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
108
0.54
0.74
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
109
0.54
0.74
1.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
109
0.54
0.74
1.2
1.4
—
—
—
0
0
(4034850)
10
60
1.70
0.73
5.1
8.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
65
556
1.24
0.72
2.4
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
41
1.73
0.70
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
303
0.73
0.69
1.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
42
1.69
0.69
2.0
2.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
324
0.74
0.68
1.9
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
176
1677
1.28
0.66
4.6
3.8
mmol/l
6.5
5.8
3.06
162
1565
(3022621) pH of Urine by Test strip
14
95
1.51
0.66
4.3
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
31
245
1.31
0.64
1.5
1.6
nmol/l
1421.5
1227.7
0.47
25
187
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
80
1.53
0.61
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
64
1.59
0.59
1.5
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
8
53
1.53
0.59
8.6
14.3
%
1.6
1.4
—
8
48
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
53
1.53
0.59
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
53
1.53
0.59
1.1
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
3.4
—
46.1
—
0
23
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
86
0.57
0.57
1.2
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
88
0.56
0.57
1.2
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
36
1.69
0.57
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
55
1.47
0.56
1.1
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
61
1.50
0.54
1.6
1.8
—
256.0
—
0
5
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
236
0.74
0.54
1.4
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
20
258
0.75
0.54
2.9
2.2
ug/g
61.9
103.0
1.07
15
207
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
191
0.71
0.53
4.4
3.9
%
32.7
31.8
—
7
129
(3019225) pH of Specimen
19
144
1.35
0.53
8.8
4.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
184
1776
1.26
0.51
5.0
3.9
mmol/l
4.6
4.7
0.44
171
1671
(3026493) Urate [Moles/volume] in Serum or Plasma
49
423
1.21
0.50
3.6
2.4
umol/l
351.2
8339.1
2.18
41
373
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
102
1.40
0.48
1.1
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
68
1.49
0.48
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
68
1.49
0.48
15.6
3.7
mmol/l
25.5
24.7
—
10
68
(3005033) Fetal Nuchal fold Thickness US
5
85
0.58
0.46
1.2
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
121
1.35
0.45
2.7
3.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
17
130
1.33
0.45
7.6
12.8
%
94.7
96.1
0.64
17
125
(4306422)
5
31
1.63
0.43
1.8
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
79
1.41
0.41
1.2
1.4
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
3.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
4.1
—
0
15
(3005570) Glucose [Moles/volume] in Urine
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
7.5
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
30
252
1.22
0.40
1.5
1.4
titre
544.0
482.9
—
5
55
(4035726)
16
124
1.31
0.40
1.7
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
35
1.44
0.39
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
67
1.36
0.38
4.6
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
206
2029
1.41
0.38
27.7
17.6
e9/l
6.9
6.6
1.16
201
1988
(3019150) Specific gravity of Urine by Refractometry
41
358
1.18
0.38
4.9
3.4
kg/l
1.0
1.0
—
8
40
(40758558) Short blood count panel - Blood
46
406
1.17
0.37
9.3
7.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
9
69
1.32
0.37
8.8
3.4
%
46.8
49.3
—
9
69
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
37
1.36
0.37
1.2
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
157
0.75
0.37
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
182
1769
1.19
0.37
5.0
3.8
mmol/l
1.4
1.4
0.31
169
1660
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
41
1.48
0.36
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
124
0.71
0.36
1.2
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
42
1.44
0.36
2.2
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
132
1381
0.88
0.35
3.2
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
45
504
0.86
0.34
2.2
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
183
1783
1.18
0.33
20.0
12.0
mg/l
22.4
21.7
0.11
156
1382
(3028707) Methadone [Presence] in Urine by Screen method
6
47
1.28
0.32
5.8
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
176
1711
1.16
0.32
4.5
3.5
mmol/l
1.3
1.3
0.41
162
1597
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
54
1.31
0.30
1.3
1.3
—
—
—
0
0
(3020891) Body temperature
7
55
1.28
0.30
5.9
4.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
184
1797
1.17
0.30
5.6
4.2
mmol/l
2.8
2.9
0.37
172
1687
(36660697) Celiac disease serology panel - Serum
20
167
1.22
0.29
1.3
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
11
85
1.31
0.28
8.5
10.6
%
0.9
0.7
0.84
11
85
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
62
1.30
0.28
1.9
2.3
—
—
—
0
0
(3013512) EKG study
46
417
1.13
0.27
3.4
3.4
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
11
86
1.29
0.26
8.5
10.6
%
1.5
1.7
0.29
11
86
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
78
1.30
0.24
2.3
2.2
u/l
47.8
40.3
—
10
72
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
38
419
0.89
0.24
3.8
3.8
%
25.2
22.3
0.44
16
173
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
46
421
1.12
0.23
2.4
2.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
315
1.13
0.23
1.5
1.3
iu/ml
27.0
30.6
—
6
94
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
316
1.13
0.22
1.4
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4211845)
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
35.2
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
262.8
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
6.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.7
—
150.7
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
482.2
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(44813793)
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000492) Spirometry study
17
197
0.85
0.20
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
7
59
1.19
0.18
1.6
1.2
—
64.3
—
0
7
(3022145) Colonoscopy Study observation
18
204
0.87
0.17
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
70
0.71
0.17
2.0
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
92
1.21
0.16
4.5
9.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
77
0.77
0.16
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
71
678
1.07
0.15
2.4
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
86
0.81
0.15
2.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
189
1.12
0.14
3.9
6.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
314
0.91
0.14
1.4
1.2
u/ml
1.0
6.4
2.35
11
132
(3013707) Erythrocyte sedimentation rate by Westergren method
131
1279
1.06
0.13
5.5
3.8
mm/h
11.5
9.4
1.05
124
1185
(3008898) HLA-B27 [Presence]
12
104
1.16
0.12
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
136
0.88
0.11
1.5
4.5
ug/l
2.0
38.0
—
7
113
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
86
1.17
0.11
1.4
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
31
290
1.08
0.11
2.1
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
14
125
1.13
0.10
5.4
2.8
e9/l
3.7
4.1
—
9
107
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
106
1.14
0.10
1.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
74
763
0.95
0.09
3.0
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
113
0.88
0.08
4.2
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
63
0.79
0.08
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
65
0.76
0.08
1.8
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
418
0.95
0.08
2.0
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
89
1.13
0.07
4.1
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
187
1.08
0.06
1.7
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
41
395
1.05
0.06
1.6
1.4
g/l
3.0
2.4
0.58
29
259
(3009542) Hematocrit [Volume Fraction] of Blood
170
1715
0.96
0.06
20.4
12.2
%
39.5
40.9
1.45
136
1363
(40761511) CBC panel - Blood by Automated count
191
1897
1.06
0.06
17.1
11.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
178
1.07
0.06
1.7
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
257
1.06
0.06
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
313
0.95
0.05
2.8
2.7
ug/l
0.6
0.8
1.15
18
169
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
22
232
0.94
0.05
1.7
1.6
—
—
—
0
0
(4010399)
12
110
1.10
0.05
1.0
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
111
1.09
0.04
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
14
148
0.94
0.02
1.9
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
12
113
1.07
0.02
2.0
1.7
g/l
1.3
1.7
0.42
12
104
(40768797) Stomach Pathology biopsy report
21
217
0.96
0.01
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
83
837
0.99
0.01
4.2
4.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
52
526
0.98
0.00
3.9
3.9
ug/l
1.7
2.0
0.39
46
474
(3016879) Cocaine [Presence] in Urine
11
106
1.04
0.00
4.0
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
114
0.96
0.00
4.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
114
0.96
0.00
4.2
1.9
—
—
—
0
0
(1002224) Polysomnography panel
10
99
1.01
0.00
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
54
541
1.00
0.00
1.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
113
0.97
0.00
4.1
1.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
61
0.98
0.00
1.5
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
65
0.92
0.00
1.7
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
76
0.92
0.00
6.7
2.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
120
1.00
0.00
1.7
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
6.5
—
0
6
(3012441) Differential panel - Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.5
—
57.0
—
0
6
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
18.3
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
135
1350
1.00
0.00
3.5
2.9
u/l
46.7
44.8
0.13
124
1286
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
8
83
0.96
0.00
6.4
2.6
u/ml
22.3
42.8
—
8
78
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
7
0.00
0.00
0.0
1.3
—
158.1
—
0
7
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.3
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCOMA_JOAG and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCOMA_JOAG.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: H7_GLAUCOMA_JOAG – Juvenile Open Angle Glaucoma

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data